ClinVar Genomic variation as it relates to human health
NM_021942.6(TRAPPC11):c.2938G>A (p.Gly980Arg)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_021942.6(TRAPPC11):c.2938G>A (p.Gly980Arg)
Variation ID: 60510 Accession: VCV000060510.13
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 4q35.1 4: 183701783 (GRCh38) [ NCBI UCSC ] 4: 184622936 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Nov 18, 2016 Apr 6, 2024 Mar 14, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_021942.6:c.2938G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_068761.4:p.Gly980Arg missense NM_199053.3:c.2938G>A NP_951008.1:p.Gly980Arg missense NC_000004.12:g.183701783G>A NC_000004.11:g.184622936G>A NG_033102.1:g.47517G>A Q7Z392:p.Gly980Arg - Protein change
- G980R
- Other names
- -
- Canonical SPDI
- NC_000004.12:183701782:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00001
Trans-Omics for Precision Medicine (TOPMed) 0.00002
Exome Aggregation Consortium (ExAC) 0.00004
The Genome Aggregation Database (gnomAD), exomes 0.00007
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
TRAPPC11 | - | - |
GRCh38 GRCh37 |
874 | 1061 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (5) |
criteria provided, multiple submitters, no conflicts
|
Mar 14, 2024 | RCV000054408.20 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Aug 29, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Autosomal recessive limb-girdle muscular dystrophy type R18
Affected status: yes
Allele origin:
germline
|
MGZ Medical Genetics Center
Accession: SCV002581874.1
First in ClinVar: Oct 15, 2022 Last updated: Oct 15, 2022
Comment:
ACMG criteria applied: PS4_MOD, PM3, PM2_SUP, PP1, PP3
|
Number of individuals with the variant: 1
Sex: female
|
|
Pathogenic
(Sep 01, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Autosomal recessive limb-girdle muscular dystrophy type R18
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Baylor Genetics
Accession: SCV000807243.2
First in ClinVar: Nov 18, 2016 Last updated: Dec 11, 2022 |
Comment:
This variant has been previously reported as disease-causing and was found once in our laboratory homozygous in a 1-year-old female with motor delays, hypotonia, elevated … (more)
This variant has been previously reported as disease-causing and was found once in our laboratory homozygous in a 1-year-old female with motor delays, hypotonia, elevated CK and transaminases. (less)
|
|
Pathogenic
(Nov 17, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Autosomal recessive limb-girdle muscular dystrophy type R18
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000945321.4
First in ClinVar: Aug 14, 2019 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 980 of the TRAPPC11 protein (p.Gly980Arg). … (more)
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 980 of the TRAPPC11 protein (p.Gly980Arg). This variant is present in population databases (rs397509417, gnomAD 0.08%). This missense change has been observed in individual(s) with TRAPPC11-related conditions (PMID: 23830518, 26322222; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 60510). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TRAPPC11 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects TRAPPC11 function (PMID: 23830518, 26912795). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Mar 14, 2024)
|
criteria provided, single submitter
Method: research
|
Autosomal recessive limb-girdle muscular dystrophy type R18
Affected status: unknown
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV004801266.2
First in ClinVar: Mar 16, 2024 Last updated: Apr 06, 2024 |
|
|
Pathogenic
(Jul 11, 2013)
|
no assertion criteria provided
Method: literature only
|
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000082885.4
First in ClinVar: Aug 04, 2013 Last updated: Sep 28, 2018 |
Comment on evidence:
In affected members of a consanguineous Syrian family with autosomal recessive limb-girdle muscular dystrophy type 2S (LGMDR18; 615356), Bogershausen et al. (2013) identified a homozygous … (more)
In affected members of a consanguineous Syrian family with autosomal recessive limb-girdle muscular dystrophy type 2S (LGMDR18; 615356), Bogershausen et al. (2013) identified a homozygous c.2938G-A transition in the TRAPPC11 gene, resulting in a gly980-to-arg (G980R) substitution at a highly conserved residue in the gryzun domain. The mutation was found by exome sequencing combined with linkage analysis and confirmed by Sanger sequencing, segregated with the disorder in the family, and was not found in several large control databases or in 100 Turkish controls. Studies of patient cells indicated an intracellular trafficking defect. In an 8-year-old Han Chinese girl with a variant of LGMDR18, Liang et al. (2015) identified compound heterozygous mutations in the TRAPPC11 gene: G980R and a splice site mutation (c.661-1G-T; 614138.0003). The mutations, which were found by targeted next-generation sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. In addition to muscular dystrophy, the patient had delayed psychomotor development with borderline cognitive function, infantile-onset cataracts, and hepatic steatosis. DeRossi et al. (2016) found that patient fibroblasts with the G980R mutation showed abnormal accumulation of lipid droplets. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
trappc11 is required for protein glycosylation in zebrafish and humans. | DeRossi C | Molecular biology of the cell | 2016 | PMID: 26912795 |
Congenital muscular dystrophy with fatty liver and infantile-onset cataract caused by TRAPPC11 mutations: broadening of the phenotype. | Liang WC | Skeletal muscle | 2015 | PMID: 26322222 |
Recessive TRAPPC11 mutations cause a disease spectrum of limb girdle muscular dystrophy and myopathy with movement disorder and intellectual disability. | Bögershausen N | American journal of human genetics | 2013 | PMID: 23830518 |
Text-mined citations for rs397509417 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.